{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:08:39Z","timestamp":1788390519273,"version":"build-2803163510"},"reference-count":37,"publisher":"Microbiology Society","issue":"11","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["GRK2504"],"award-info":[{"award-number":["GRK2504"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,20]]},"abstract":"<jats:p>Human herpesvirus-8 (HHV-8), also known as Kaposi\u2019s sarcoma-associated herpesvirus, is a human oncogenic herpesvirus that is responsible for several diseases including Kaposi\u2019s sarcoma (KS). KS prevalence varies dramatically, although emergence increases considerably with human immunodeficiency virus -1 (HIV-1) co-infection, making it one of the most common cancers in HIV-1 patients and sub-Saharan African men, even prior to the HIV-1 epidemic in Africa. Studies have shown that neutralizing antibodies exist in HHV-8-infected sera, which are most likely targeted to viral lytic surface glycoproteins, such as glycoprotein K8.1 (gpK8.1) and gHgL. Fifty-eight HHV-8-positive serum samples were tested for the levels of gpK8.1- and gHgL-binding antibodies and <jats:italic>in vitro<\/jats:italic> HHV-8-neutralizing capacity. Each sample was then categorized according to the disease status, which included asymptomatic infection, active KS and remission from KS, and the three measured parameters were compared between the disease groups. We show that neutralizing capacity in infected patient sera increases with remission of KS. Interestingly, antibodies targeting gpK8.1, but not gHgL, were also found to be increased during active disease and remission. Comparison of neutralizing capacity and antibody levels on an individual patient basis revealed that antibody levels, primarily targeting gHgL, are correlated with serum neutralizing response in sub-lingual Kaposi sarcoma (SLK) cells. Adsorption of gHgL or gpK8.1 antibodies from human sera removed the neutralizing response in SLK cells, although some non-specific removal of antibodies from the sera means that this result should be interpreted with caution. Taken collectively, these results suggest that glycoproteins, such as gHgL, are targets for neutralizing antibodies. Furthermore, our data imply that recovery from KS is associated with increased neutralizing capacity, suggesting that neutralizing antibodies may contribute to KS resolution. However, it is vital for further work to be completed in order to elucidate this relationship.<\/jats:p>","DOI":"10.1099\/jgv.0.002044","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T15:17:44Z","timestamp":1732115864000},"source":"Crossref","is-referenced-by-count":4,"title":["Increased human herpesvirus-8 neutralizing response during remission from Kaposi\u2019s sarcoma"],"prefix":"10.1099","volume":"105","author":[{"given":"Hannah C.","family":"Byren","sequence":"first","affiliation":[{"name":"Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Holzer","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Korn","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Backovic","sequence":"additional","affiliation":[{"name":"Pasteur Institute, 25-28 Rue du Dr Roux, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen G.","family":"Harrer","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Immunodeficiency Section, Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Bergmann","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Immunodeficiency Section, Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harrer","sequence":"additional","affiliation":[{"name":"FAU Profile Center Immunomedicine (FAU I-MED), Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"},{"name":"Infectious Diseases and Immunodeficiency Section, Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9929-1198","authenticated-orcid":false,"given":"Frank","family":"Neipel","sequence":"additional","affiliation":[{"name":"FAU Profile Center Immunomedicine (FAU I-MED), Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"},{"name":"Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg, Schlossplatz 1, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225692"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0060-9"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.03.009"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.23.11583-11593.2001"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.16.7517-7527.2001"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2805"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200005270-00053"},{"key":"R8","first-page":"3735","article-title":"Disseminated Kaposi\u2019s sarcoma--full regression after withdrawal of immunosuppressive therapy: report of a case","volume":"19","author":"Wijnveen","year":"1987","journal-title":"Transplant Proc"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200308150-00015"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.2.283"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91619-9"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27623-8"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22683"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00490.x"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004046"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200402200-00015"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200406180-00004"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20167"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1086\/386371"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071254"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy654"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15605"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.071"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.3390\/v12030256"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.12.5488-5491.2003"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27849"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2011.03.012"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.03.049"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29329"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1086\/345866"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00832-23"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01876-18"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00630-19"},{"key":"R34","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.03.010","article-title":"Immunization with components of the viral fusion apparatus elicits antibodies that neutralize epstein-barr virus in B cells and epithelial cells","volume":"50","author":"Bu","year":"2019","journal-title":"Immunity"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir872"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.83470-0"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199818000-00018"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/jgv.0.002044?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T15:17:48Z","timestamp":1732115868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/jgv.0.002044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,20]]}},"URL":"https:\/\/doi.org\/10.1099\/jgv.0.002044","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}